Skip to main content
Premium Trial:

Request an Annual Quote

Lion Licenses SRS to Johnson & Johnson PRD

NEW YORK, Jan. 22-Lion Bioscience has licensed its SRS bioinformatics platform to Johnson & Johnson Pharmaceutical Research and Development for two years, the company said today.


The pharmaceutical research company will have access to Lion's integration software and its Prisma database synchronization program.


The company did not disclose financial specifics of the deal.


Last week, Lion announced a similar dealwith Eli Lilly.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.